Table 1 Clinical characteristics of patients included in the plasma KSHV DNA and miRNA detection

From: A Kaposi’s sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy

Variables

Non-DCM (n = 937)

DCM (n = 696)

p value

Age, years

59 ± 12

56 ± 14

0.010a

Female, n (%)

533 (56.9%)

247 (35.3%)

<0.001b

Smoking, n (%)

252 (26.9%)

243 (35.1%)

0.001b

Heart rate, beats/min

78 ± 14

85 ± 18

<0.001a

SBP, mmHg

133 ± 22

125 ± 22

<0.001a

DBP, mmHg

80 ± 14

80 ± 15

0.108a

LVEF, %

60.93 ± 8.99

34.06 ± 11.89

<0.001a

LVEDD, mm

47.02 ± 4.78

65.06 ± 8.33

<0.001a

NYHA class II, III, or IV

260 (27.7%)

652 (93.7%)

<0.001b

Hypertension

450 (48.0%)

260 (37.4%)

<0.001b

Type 2 diabetes

151 (16.1%)

104 (14.9%)

0.519b

Hyperlipidemia

110 (11.7%)

61 (8.8%)

0.052b

  1. Age, heart rate, SBP, DBP, LVEF, and LVEDD are given as mean ± SD, and other values as the number of individuals (n) with percentage (n/N) in parentheses
  2. DCM dilated cardiomyopathy, HF heart failure, SBP systolic blood pressure, DBP diastolic blood pressure, LVEF left ventricular ejection fraction, LVEDD left ventricular end diastolic diameter
  3. aBy the Mann–Whitney U-test
  4. bBy the χ2 test or Fisher’s exact test
Back to article page